Clinical Trials Logo

Filter by:
NCT ID: NCT01337271 Completed - Respiratory Failure Clinical Trials

Performance of Neurally Adjusted Ventilatory Assist (NAVA) During Spontaneous Breathing Trial

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to compare a new mode of mechanical ventilation (NAVA, or Neurally adjusted Ventilatory assist) with a traditional mode (Pressure Support ventilation) on its the ability to detect patients ready for extubation (liberation from mechanical ventilation).

NCT ID: NCT01335698 Completed - HIV Clinical Trials

Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients

PRINCE2
Start date: May 27, 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to describe the safety, efficacy, and pharmacokinetics of a regimen of atazanavir powder boosted with ritonavir and an optimized dual nucleoside reverse transcriptase inhibitor in pediatric patients aged ≥3 months to <11 years.

NCT ID: NCT01335594 Completed - Clinical trials for Sleep Apnea, Obstructive

Evaluation of Swallowing in Patients With Obstructive Sleep Apnea

Start date: February 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to test the hypothesis that obstructive sleep apnea syndrome is associated with deviant pharyngeal swallowing function, using clinical, endoscopical and manometric evaluation.

NCT ID: NCT01335321 Completed - Osteoarthritis Clinical Trials

Evaluation of the Effect of Adding Corticosteroid to Viscosupplementation

Start date: March 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate if the investigators can achieve better early outcomes adding triamcinolone to the viscosupplementation procedure.

NCT ID: NCT01334931 Completed - Radiation Injury Clinical Trials

Use of Large Field of View During Image Acquisition for Coronary Angiography

XRay Reduction
Start date: April 2011
Phase: Phase 3
Study type: Interventional

Coronary angiography exposes patients and physicians to ionizing radiation. The purpose of this study is to evaluate the routine use of large field of view during image acquisition for coronary angiography. Patients with indication of diagnostic coronary angiography will be randomized for the use of either large field of view during image acquisition or medium field of view. Patients, physician and nurse radiation exposure will be measured by digital dosimeter.

NCT ID: NCT01333787 Completed - Constipation Clinical Trials

Dietary Fiber Mixture in Constipated Pediatric Patients

MIXFIBER
Start date: February 2008
Phase: Phase 4
Study type: Interventional

The purpose this study was to to evaluate the therapeutic effect of a fibers mixture in the treatment of chronic constipation and on the colonic transit time in children.

NCT ID: NCT01333579 Completed - Stroke Clinical Trials

Low-frequency Transcranial Magnetic Stimulation To Enhance Motor Recovery In The Subacute Phase After Stroke

Start date: February 2008
Phase: Phase 1
Study type: Interventional

Low-frequency repetitive transcranial magnetic stimulation (rTMS) of the unaffected hemisphere (UH) transiently improves motor function in patients in the chronic phase after stroke. The goal of this study is to investigate effects on motor recovery of low-frequency rTMS of the UH, administered in the subacute phase after stroke.

NCT ID: NCT01332812 Completed - Clinical trials for Postoperative Cognitive Dysfunction

Dexamethasone for the Prevention of Postoperative Cognitive Dysfunction

Start date: January 2011
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the possible effect of dexamethasone on prevention of cognitive dysfunction in the postoperative period of elderly patients undergoing to surgery under general anesthesia.

NCT ID: NCT01332071 Completed - Clinical trials for Diabetes Mellitus, Type 2

Avandamet Bioequivalence Study Brazil - Fed Administration

Start date: November 2009
Phase: Phase 1
Study type: Interventional

The study is prospective, open-label, randomized, crossover, with 02 treatments, 02 sequences, and 02 periods. The volunteers received, in each period, the reference or the test formulation after standardized meals.

NCT ID: NCT01331850 Completed - Clinical trials for Hepatitis C, Chronic

A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C

Start date: May 2011
Phase: Phase 2
Study type: Interventional

This randomized, open-label, multi-center study will evaluate the sustained virological response, pharmacokinetics and safety of various combinations of danoprevir/ritonavir with Copegus plus RO5024048 and/or Pegasys in patients with chronic hepatitis C infection. Patients will be divided into 2 separate cohorts. Cohort A, previous partial responders, will be randomized to Groups 1-3 and cohort B, previous null responders, will be randomized to Groups 4-6. Patients in all groups will receive danoprevir 100 mg twice a day and ritonavir 100 mg twice a day for 24 weeks. In addition, Groups 1 and 4 will receive RO5024048 1000 mg twice a day and Copegus 1000 mg or 1200 mg twice a day for 24 weeks; Group 2 will receive Pegasys 180 microgram subcutaneously once weekly and Copegus 1000 mg or 1200 mg twice a day for 24 weeks; Groups 3, 5 and 6 will receive RO5024048 1000 mg twice a day, Pegasys 180 microgram subcutaneously once weekly and Copegus 1000 mg or 1200 mg twice a day for 24 weeks. In addition, patients in Group 6 will receive another 24 weeks of Pegasys plus Copegus treatment.